| Application no. and date | 04758372.9 (espacenet) (Federated) (European Patent Register), 20040326 | | Patent/reg. no. and date | DK/EP 1608685, 20070221 | | Publication date | 20051228 | | Priority no. and date | US 458790 P, 20030328 | | EP pub. no. and date |
EP 1608685 20051228 | | Effective date | | | Applicant/owner | REGENERON PHARMACEUTICALS, INC., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | P8070678DK00E | | Inventor | WIEGAND, Stanley, J., 15 Fox Run Road
Croton-on-Hudson, NY 10520, US,
SLEEMAN, Mark, W., 118 Lake Drive
Mahopac, NY 10541, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/7088 (2006.01) , A61P 3/10 (2006.01) , C07K 19/00 (2006.01) , C07K 14/52 (2006.01) , C07K 14/71 (2006.01) , C07K 16/28 (2006.01) | | Title | VEGF antagonister til behandlingen af diabetes | | Int. application no. | US2004009246 | | Int. publication no. | WO2004087206 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
